Regulates the expression of cyclin D2 and E2 and induces G1 arrest of human liver cancer cells. Reduced expression in HCC. Systemic administration inhibe cancer cell proliferation and induced apoptosis in HCC. Here, CCND2 is linked to hepatocellular carcinoma.